Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-24-000218

COFO and Secretary sold 15,558 shares at an average $29.91 ($465,286)

  • COFO and Secretary acquired 15,558 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Schuth Alexander O. · COFO and Secretary

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2024-11-07 Exercise or conversion : show line 1 in the form 10b5-1 +15,558 $5.28 $82,146 193,624 D
2024-11-07 Sale : show line 2 in the form 10b5-1 −12,333 $29.68 $366,043 181,291 D
2024-11-07 Sale : show line 3 in the form 10b5-1 −2,925 $30.72 $89,856 178,366 D
2024-11-07 Sale : show line 4 in the form 10b5-1 −300 $31.29 $9,387 178,066 D
Open-market sales · 15,558 sh · avg $29.91 · $465,286

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-11-07 Exercise or conversion : show line 5 in the form 10b5-1 Stock Option (right to buy) −15,558 53,379 D
Loading xslF345X05/wk-form4_1731447884.xml…